India restricts exports of common drugs as threat of Coronavirus rises

NEW DELHI: India, the world's largest maker of generic drugs, on Tuesday restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the Coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) said the export of 26 active pharmaceutical ingredients (APIS) and formulations would require license.

Though India is a source of about 20 per cent of the world's generic drug supply, pharma companies in the country are dependent on China for two-thirds of the chemical components needed to make them.

The outbreak of Coronavirus has shut factories in China and impacted supplies, leading to fears of a shortage of drugs and medicines.

“Export of specified APIS and formulations made from these APIS is hereby restricted with immediate effect and till further orders,” the DGFT said in the notification.

While three new cases of Coronavirus were reported in India on Monday, “high viral load” was detected in six people who had been in contact with a Coronavirus-infected patient. Since its outbreak in China, the deadly virus has killed more than 3,000 people globally. India's API imports stand at around $3.5 billion per year, and around 70 per cent, or $2.5 billion, come from China.